HESI LPN
Pharmacology HESI 55 Questions 2023 Questions
Question 1 of 5
A client with a history of deep vein thrombosis is prescribed apixaban. The nurse should monitor for which potential adverse effect?
Correct Answer: A
Rationale: The correct answer is A: Increased risk of bleeding. Apixaban is an anticoagulant medication that works by preventing blood clots. While this is beneficial for individuals with a history of deep vein thrombosis, it also increases the risk of bleeding. Therefore, the nurse should monitor the client for signs of bleeding, such as easy bruising, prolonged bleeding from cuts, or blood in the urine or stool. Monitoring for bleeding is crucial to ensure the client's safety and to take appropriate actions if necessary.
Question 2 of 5
A client with a history of heart failure is prescribed digoxin. The nurse should monitor for which potential side effect?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
A client with rheumatoid arthritis is prescribed hydroxychloroquine. What instruction should the nurse include in the client's teaching plan?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A client with a history of atrial fibrillation is prescribed amiodarone. The nurse should monitor for which potential side effect?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
A client with diabetes mellitus type 2 is prescribed dapagliflozin. The nurse should monitor for which potential adverse effect?
Correct Answer: A
Rationale: Dapagliflozin, a medication used in diabetes mellitus type 2, is associated with an increased risk of genital infections. This risk is due to its mechanism of action that involves promoting the excretion of glucose through the urine, creating a favorable environment for microbial growth in the genital area. Therefore, monitoring for genital infections is essential when a client is prescribed dapagliflozin.